BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23291208)

  • 21. Dual diagnosis subtypes in urban substance abuse and mental health clinics.
    Hien D; Zimberg S; Weisman S; First M; Ackerman S
    Psychiatr Serv; 1997 Aug; 48(8):1058-63. PubMed ID: 9255839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center.
    Lambert MT; Griffith JM; Hendrickse W
    Psychiatr Serv; 1996 Oct; 47(10):1104-7. PubMed ID: 8890339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics of cough mixture abusers referred to three substance abuse clinics in Hong Kong: a retrospective study.
    Tang AK; Tang WK; Liang HJ; Chan F; Mak SC; Ungvari GS
    East Asian Arch Psychiatry; 2012 Dec; 22(4):154-9. PubMed ID: 23271584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa.
    Weich L; Pienaar W
    Afr J Psychiatry (Johannesbg); 2009 Aug; 12(3):213-7. PubMed ID: 19750250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.
    Schubiner H; Tzelepis A; Milberger S; Lockhart N; Kruger M; Kelley BJ; Schoener EP
    J Clin Psychiatry; 2000 Apr; 61(4):244-51. PubMed ID: 10830144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders.
    Cassano GB; Pini S; Saettoni M; Rucci P; Dell'Osso L
    J Clin Psychiatry; 1998 Feb; 59(2):60-8. PubMed ID: 9501887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comorbid mental disorders in substance users from a single catchment area--a clinical study.
    Langås AM; Malt UF; Opjordsmoen S
    BMC Psychiatry; 2011 Feb; 11():25. PubMed ID: 21314980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliability of dual diagnosis. Substance dependence and psychiatric disorders.
    Bryant KJ; Rounsaville B; Spitzer RL; Williams JB
    J Nerv Ment Dis; 1992 Apr; 180(4):251-7. PubMed ID: 1556565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adolescent substance abuse and psychiatric comorbidities.
    Deas D; Brown ES
    J Clin Psychiatry; 2006 Jul; 67(7):e02. PubMed ID: 17107227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
    Møller T; Linaker OM
    Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance use disorders among psychotic patients admitted to inpatient psychiatric care.
    Helseth V; Lykke-Enger T; Johnsen J; Waal H
    Nord J Psychiatry; 2009; 63(1):72-7. PubMed ID: 19034727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital.
    Greenfield SF; Weiss RD; Tohen M
    Community Ment Health J; 1995 Jun; 31(3):265-77. PubMed ID: 7621663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of psychiatric disorders among young injection drug users.
    Mackesy-Amiti ME; Donenberg GR; Ouellet LJ
    Drug Alcohol Depend; 2012 Jul; 124(1-2):70-8. PubMed ID: 22226707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comorbid substance abuse and recovery from acute psychiatric relapse.
    Sanguineti VR; Samuel SE
    Hosp Community Psychiatry; 1993 Nov; 44(11):1073-6. PubMed ID: 8288176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between psychotic symptoms and substance use in young offenders.
    Degenhardt L; Coffey C; Hearps S; Kinner SA; Borschmann R; Moran P; Patton G
    Drug Alcohol Rev; 2015 Nov; 34(6):673-82. PubMed ID: 26084677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing the psychosis continuum: differential impact of genetic and nongenetic risk factors and comorbid psychopathology across the entire spectrum of psychosis.
    Binbay T; Drukker M; Elbi H; Tanık FA; Özkınay F; Onay H; Zağlı N; van Os J; Alptekin K
    Schizophr Bull; 2012 Sep; 38(5):992-1002. PubMed ID: 21525167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Hasin DS; Stinson FS; Ogburn E; Grant BF
    Arch Gen Psychiatry; 2007 Jul; 64(7):830-42. PubMed ID: 17606817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychotic symptoms in combat-related posttraumatic stress disorder.
    David D; Kutcher GS; Jackson EI; Mellman TA
    J Clin Psychiatry; 1999 Jan; 60(1):29-32. PubMed ID: 10074874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.